Development of a CD123xCD3 bispecific antibody to treat acute myeloid leukemia (AML)

被引：0
|
作者：
Gaudet, Francois
Nemeth, Jennifer F.
McDaid, Ronan
Li, Yingzhe
Harman, Benjamin
Millar, Hillary
Teplyakov, Alexey
Wheeler, John
Luo, Jinquan
Tam, Susan
Wu, Sheng-Jiun
Chen, Emily
Babich, Alexander
Elsayed, Yusri
Attar, Ricardo
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-1492
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1492
引用
收藏
页数：3
相关论文
共 50 条
  • [11] A Clinical Phase 1B Study of the CD3xCD123 Bispecific Antibody APVO436 in Patients with Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
    Uckun, Fatih M.
    Lin, Tara L.
    Mims, Alice S.
    Patel, Prapti
    Lee, Cynthia
    Shahidzadeh, Anoush
    Shami, Paul J.
    Cull, Elizabeth
    Cogle, Christopher R.
    Watts, Justin
    CANCERS, 2021, 13 (16)
  • [12] Diagnostic and Prognostic Value of CD123 in Acute Myeloid Leukemia (AML)
    Eldin, Taghreed Kamal
    Abdelsalam, Eman M. Nagiub
    Razek, Ghadeer Abdel
    Nafady, Howaida
    Saleh, Mostafa F. Mohammed
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S272 - S273
  • [13] Treatment with DC/AML Fusion Vaccine and CD3xCD123 Bi-Specific T-Cell Engager (CD123-CODV-TCE) for Treatment of Acute Myeloid Leukemia
    Stroopinsky, Dina
    Koshy, Anita G.
    Liegel, Jessica J.
    Nahas, Myrna
    Cheloni, Giulia
    Hauser, Joshua
    Torres, Daniela
    Bindal, Poorva
    Rahimian, Maryam
    Bisharat, Lina
    Fraenkel, Paula
    Yildirim, Ozlem
    Bonnevaux, Helene
    Guerif, Stephane
    Kufe, Donald
    Rosenblatt, Jacalyn
    Avigan, David
    BLOOD, 2021, 138
  • [14] Preclinical characterization of MT114, a novel CD33/CD3-bispecific BiTE antibody for the treatment of acute myeloid leukemia (AML)
    Henn, Anja
    Friedrich, Matthias
    Kischel, Roman
    Lutterbuese, Ralf
    Schneider, Katja
    Mueller, Peter
    Baeuerle, Patrick A.
    Raum, Tobias
    Kufer, Peter
    Rattel, Benno
    CANCER RESEARCH, 2012, 72
  • [15] Anti-IL1RAP/CD3 Bispecific Antibody (BsAb) Is a Promising Novel and Effective Therapy for Acute Myeloid Leukemia (AML)
    Meng, Weixu
    Del Real, Marissa
    Wei, Guowei
    Hernandez, Rochelle
    Marcucci, Emanuela
    Lin, Allen
    Mcdonald, Tinisha
    Zhao, Dandan
    Wu, Herman
    Carlesso, Nadia
    Kwak, Larry W.
    Li, Ling
    Kuo, Ya-Huei
    Stein, Anthony S.
    Pullarkat, Vinod
    Nakamura, Ryotaro
    Rosen, Steven T.
    Forman, Stephen J.
    Zhang, Bin
    Budde, Lihua
    Marcucci, Guido
    BLOOD, 2017, 130
  • [16] Flotetuzumab, an Investigational CD123 x CD3 Bispecific Dart® Protein, in Salvage Therapy for Primary Refractory and Early Relapsed Acute Myeloid Leukemia (AML) Patients
    Uy, Geoffrey L.
    Aldoss, Ibrahim
    Foster, Matthew C.
    Sallman, David A.
    Sweet, Kendra L.
    Rizzieri, David A.
    Sayre, Peter H.
    Advani, Anjali S.
    Emadi, Ashkan
    Wieduwilt, Matthew J.
    Vey, Norbert
    Ciceri, Fabio
    Carrabba, Matteo Giovanni
    Moyo, Tamara
    Church, Sarah E.
    Rettig, Michael P.
    Arellano, Martha L.
    Godwin, John E.
    Lowenberg, Bob
    Huls, Gerwin
    Ravandi, Farhad
    Muth, John
    Tran, Kathy
    Jongen-Lavrencic, Mojca
    Timmeny, Erin
    Topp, Max S.
    Paolini, Stefania
    Guo, Kuo
    Curtis, Teia
    Zhao, Jian
    Vadakekolathu, Jayakumar
    Wigginton, Jon M.
    Bonvini, Ezio
    Rutella, Sergio
    Walter, Roland B.
    Davidson-Moncada, Jan K.
    DiPersio, John F.
    BLOOD, 2019, 134
  • [17] Biting Leukemia: CD33/CD3 Bispecific Antibody Constructs for the Treatment of AML
    Subklewe, Marion
    ANNALS OF HEMATOLOGY, 2017, 96 : S46 - S46
  • [18] FLT3/CD99 Bispecific Antibody-Based Nanoparticles for Acute Myeloid Leukemia
    Ali, Atham
    Phan, Alvin
    Vaikari, Vijaya
    Park, Mincheol
    Pospiech, Mateusz
    Chu, Ryan
    Meng, Yiting
    MacKay, J. Andrew
    Alachkar, Houda
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (08): : 1946 - 1962
  • [19] An anti-CD3/anti-CLL-1 bispecific antibody for the treatment of acute myeloid leukemia
    Leong, Steven R.
    Sukumaran, Siddharth
    Hristopoulos, Maria
    Totpal, Klara
    Stainton, Shannon
    Lu, Elizabeth
    Wong, Alfred
    Tam, Lucinda
    Newman, Robert
    Vuillemenot, Brian R.
    Ellerman, Diego
    Gu, Chen
    Mathieu, Mary
    Dennis, Mark S.
    Nguyen, Allen
    Zheng, Bing
    Zhang, Crystal
    Lee, Genee
    Chu, Yu-Waye
    Prell, Rodney A.
    Lin, Kedan
    Laing, Steven T.
    Polson, Andrew G.
    BLOOD, 2017, 129 (05) : 609 - 618
  • [20] Immunoprofiling of Normal Human Donor Blood Identified Potential Pharmacodynamic Markers for JNJ-63709178 (CD123xCD3) Duobody® Antibody Treatment
    Babich, Alexander
    Li, Yingzhe
    Gaudet, Francois
    Huang, Fei
    Sasser, Kate
    Salvati, Mark
    Kalota, Anna
    BLOOD, 2016, 128 (22)
12345